Index of reports
> Cases with Myelodysplastic Syndrome (4)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Probenecid where reactions include myelodysplastic syndrome. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Probenecid side effects in male
Reported by a physician from Belgium on 2012-08-01
Patient: male
Reactions: Therapeutic Response Decreased, Myelodysplastic Syndrome
Drug(s) suspected as cause:
Aranesp
Dosage: 500 unknown, q3wk
Indication: Acute Myeloid Leukaemia
Start date: 2011-12-01
End date: 2012-04-01
Probenecid
Dosage: unk
Indication: Nephropathy Toxic
Start date: 2011-11-01
End date: 2012-04-01
Vistide
Dosage: unk
Indication: Cytomegalovirus Infection
Start date: 2011-11-01
End date: 2012-04-01
Other drugs received by patient: Mabthera; Solian; Medrol; Omeprazole; Neoral
Possible Probenecid side effects in male
Reported by a physician from Belgium on 2012-07-25
Patient: male
Reactions: Therapeutic Response Decreased, Myelodysplastic Syndrome
Drug(s) suspected as cause:
Aranesp
Dosage: 500 unknown, q3wk
Indication: Acute Myeloid Leukaemia
Start date: 2011-12-01
End date: 2012-04-01
Probenecid
Dosage: unk
Indication: Nephropathy Toxic
Start date: 2011-11-01
End date: 2012-04-01
Vistide
Dosage: unk
Indication: Cytomegalovirus Infection
Start date: 2011-11-01
End date: 2012-04-01
Other drugs received by patient: Medrol; Solian; Mabthera; Omeprazole; Neoral
Possible Probenecid side effects in 37 year old male
Reported by a physician from Belgium on 2012-07-04
Patient: 37 year old male, weighing 58.0 kg (127.6 pounds)
Reactions: Therapeutic Response Decreased, Myelodysplastic Syndrome
Drug(s) suspected as cause:
Aranesp
Dosage: 500 mug, q3wk
Indication: Acute Myeloid Leukaemia
Start date: 2011-12-01
Probenecid
Dosage: unk
Indication: Nephropathy Toxic
Start date: 2011-11-01
End date: 2012-04-01
Vistide
Dosage: unk
Indication: Cytomegalovirus Infection
Start date: 2011-11-01
End date: 2012-04-01
Other drugs received by patient: Mabthera; Medrol; Solian; Omeprazole; Neoral; Mabthera
Possible Probenecid side effects in 37 year old male
Reported by a health professional (non-physician/pharmacist) from Belgium on 2012-06-26
Patient: 37 year old male, weighing 58.0 kg (127.6 pounds)
Reactions: Therapeutic Response Decreased, Myelodysplastic Syndrome
Drug(s) suspected as cause:
Aranesp
Dosage: 500 mug, q3wk
Indication: Acute Myeloid Leukaemia
Start date: 2011-12-01
Probenecid
Dosage: unk
Indication: Nephropathy Toxic
Start date: 2011-11-01
End date: 2012-04-01
Vistide
Dosage: unk
Indication: Cytomegalovirus Infection
Start date: 2011-11-01
End date: 2012-04-01
Other drugs received by patient: Solian; Medrol; Mabthera; Neoral; Omeprazole; Mabthera
|